L2 Asset Management, LLC

Position in JNJ — Johnson & Johnson

CIK 1686988 Wayland, MA

Position in JNJ

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$804,576

+$49,746 QoQ

Shares Held

3,168

+2.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#3,234

of 4,676 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

L2 Asset Management, LLC holds $26,468,691 across 6 Drug Manufacturers - General names. JNJ ranks #6 (3.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	31,241	$11,312,990
2	GILD	Gilead Sciences, Inc.	64,505	$8,149,561
3	BMY	Bristol Myers Squibb Co	45,073	$2,597,106
4	ABBV	AbbVie Inc.	9,799	$2,465,820
5	MRK	Merck & Co., Inc.	8,861	$1,138,638
6	JNJ	Johnson & Johnson This page	3,168	$804,576

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$804,576	3,168	+2.6%	Shares	Sole	2026-08-13
2026-03-31	$754,830	3,088	-40.6%	Shares	Sole	2026-05-15
2025-12-31	$1,076,760	5,203	+4.9%	Shares	Sole	2026-02-17
2025-09-30	$919,312	4,958	+61.6%	Shares	Sole	2025-11-14
2025-06-30	$468,637	3,068	+40.7%	Shares	Sole	2025-08-14
2025-03-31	$361,697	2,181	—	Shares	Sole	2025-05-15
No filing history on record for this holder in this stock.